Matches in SemOpenAlex for { <https://semopenalex.org/work/W3026646261> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W3026646261 endingPage "1172" @default.
- W3026646261 startingPage "1165" @default.
- W3026646261 abstract "Abstract Aim The purpose of this study was to evaluate the prognostic factors of patients with stage IIIC1r cervical cancer who underwent concurrent chemoradiotherapy. Methods A total of 134 patients treated with chemoradiotherapy for cervical cancer with pelvic and/or paraaortic lymph node metastasis (PALNM) were enrolled in this study. Clinical variables were investigated through review of the patients' medical records. Results The 5‐year overall survival (OS) rate in patients with stage IIICr cervical cancer was 70.5%. Age, PALNM, parametrial invasion, T stage, pelvic side wall invasion, differentiation, lymphovascular space involvement and high squamous cell carcinoma antigen level (>8 ng/mL) were prognostic factors for survival. The 5‐year OS rate of patients with stage IIIC1r was 74.5%, and that of stage IIIC2r was 38.1% ( P ‐value = 0.012). The 5‐year OS rate of patients with stage IIIC1r with the presence of pelvic side wall invasion was 48.3% and that in its absence was 83.0% ( P ‐value < 0.001). The 5‐year OS rate of patients with stage IIIC1r with the presence of parametrial invasion was 68.9% and that in its absence was 82.4% ( P ‐value = 0.031). In multivariable analysis via backward conditional modeling, age, PALNM and pelvic side wall invasion were independent prognostic factors for survival of stage IIICr. Age and pelvic side wall invasion were independent prognostic factors for survival of stage IIIC1r cervical cancer. Conclusion In stage IIICr cervical cancer, patients with PALNM, and/or pelvic side wall invasion can expect to have a poor prognosis. Particularly, pelvic side wall invasion in stage IIIC1r is an independent prognosis factor." @default.
- W3026646261 created "2020-05-29" @default.
- W3026646261 creator A5045644646 @default.
- W3026646261 creator A5056191842 @default.
- W3026646261 creator A5079797975 @default.
- W3026646261 date "2020-05-19" @default.
- W3026646261 modified "2023-10-18" @default.
- W3026646261 title "Prognostic factors in women with cervical cancer stage IIIC1r treated with concurrent chemoradiotherapy" @default.
- W3026646261 cites W1975181797 @default.
- W3026646261 cites W1999317426 @default.
- W3026646261 cites W2110057444 @default.
- W3026646261 cites W2141788926 @default.
- W3026646261 cites W2330104938 @default.
- W3026646261 cites W2467169423 @default.
- W3026646261 cites W2888205856 @default.
- W3026646261 cites W2889646458 @default.
- W3026646261 cites W2899416224 @default.
- W3026646261 cites W2910253964 @default.
- W3026646261 cites W2927096073 @default.
- W3026646261 cites W2955034183 @default.
- W3026646261 cites W4211132630 @default.
- W3026646261 doi "https://doi.org/10.1111/jog.14305" @default.
- W3026646261 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32428977" @default.
- W3026646261 hasPublicationYear "2020" @default.
- W3026646261 type Work @default.
- W3026646261 sameAs 3026646261 @default.
- W3026646261 citedByCount "7" @default.
- W3026646261 countsByYear W30266462612021 @default.
- W3026646261 countsByYear W30266462612022 @default.
- W3026646261 countsByYear W30266462612023 @default.
- W3026646261 crossrefType "journal-article" @default.
- W3026646261 hasAuthorship W3026646261A5045644646 @default.
- W3026646261 hasAuthorship W3026646261A5056191842 @default.
- W3026646261 hasAuthorship W3026646261A5079797975 @default.
- W3026646261 hasConcept C121608353 @default.
- W3026646261 hasConcept C126322002 @default.
- W3026646261 hasConcept C143998085 @default.
- W3026646261 hasConcept C146357865 @default.
- W3026646261 hasConcept C151730666 @default.
- W3026646261 hasConcept C2776283816 @default.
- W3026646261 hasConcept C2778220009 @default.
- W3026646261 hasConcept C2778424827 @default.
- W3026646261 hasConcept C2778740770 @default.
- W3026646261 hasConcept C2779013556 @default.
- W3026646261 hasConcept C2779808985 @default.
- W3026646261 hasConcept C2910158674 @default.
- W3026646261 hasConcept C2910227796 @default.
- W3026646261 hasConcept C71924100 @default.
- W3026646261 hasConcept C86803240 @default.
- W3026646261 hasConceptScore W3026646261C121608353 @default.
- W3026646261 hasConceptScore W3026646261C126322002 @default.
- W3026646261 hasConceptScore W3026646261C143998085 @default.
- W3026646261 hasConceptScore W3026646261C146357865 @default.
- W3026646261 hasConceptScore W3026646261C151730666 @default.
- W3026646261 hasConceptScore W3026646261C2776283816 @default.
- W3026646261 hasConceptScore W3026646261C2778220009 @default.
- W3026646261 hasConceptScore W3026646261C2778424827 @default.
- W3026646261 hasConceptScore W3026646261C2778740770 @default.
- W3026646261 hasConceptScore W3026646261C2779013556 @default.
- W3026646261 hasConceptScore W3026646261C2779808985 @default.
- W3026646261 hasConceptScore W3026646261C2910158674 @default.
- W3026646261 hasConceptScore W3026646261C2910227796 @default.
- W3026646261 hasConceptScore W3026646261C71924100 @default.
- W3026646261 hasConceptScore W3026646261C86803240 @default.
- W3026646261 hasIssue "7" @default.
- W3026646261 hasLocation W30266462611 @default.
- W3026646261 hasOpenAccess W3026646261 @default.
- W3026646261 hasPrimaryLocation W30266462611 @default.
- W3026646261 hasRelatedWork W1991669069 @default.
- W3026646261 hasRelatedWork W2009367535 @default.
- W3026646261 hasRelatedWork W2056061117 @default.
- W3026646261 hasRelatedWork W2082157055 @default.
- W3026646261 hasRelatedWork W2096654841 @default.
- W3026646261 hasRelatedWork W2412278863 @default.
- W3026646261 hasRelatedWork W2809976679 @default.
- W3026646261 hasRelatedWork W2905376367 @default.
- W3026646261 hasRelatedWork W4224309775 @default.
- W3026646261 hasRelatedWork W4248259499 @default.
- W3026646261 hasVolume "46" @default.
- W3026646261 isParatext "false" @default.
- W3026646261 isRetracted "false" @default.
- W3026646261 magId "3026646261" @default.
- W3026646261 workType "article" @default.